(Reuters) -Several pharmaceutical companies have said they will sell drugs direct to patients in the U.S. and offered ...

The Cambridge company has aggressively reduced costs through measures including staff cuts and lower spending on research and ...

Universal Display Corporation (Nasdaq: OLED) (UDC), enabling energy-efficient displays and lighting with its UniversalPHOLED technology and materials, today announced that it has entered into a defini ...

Committee seeks stronger trial design, urging SII to sharpen objectives and raise scientific standards for proving CERVAVAC’s ...

Codexis reported a loss of $19.6 million, or 22 cents a share for the quarter ended Sept. 30, compared with a loss of $20.6 million, or 29 cents a share. Analysts polled by FactSet expected a more ...

Moderna beats Q3 forecasts as cost-cutting offsets weaker COVID vaccine sales and new mRNA cancer trials advance.

Ligand is increasing its 2025 full year financial guidance. The Company now expects total core revenue of $225 million to ...

The agreement will also secure a $150 price for future weight loss pills from Novo Nordisk and Eli Lilly—at least initially.

For as long as I can remember, I’ve been a word maven, which I got from my mother, a word maven of the first water. For example, instead of playing patty cake, we played word games of all sorts. The ...

Eli Lilly and Novo Nordisk have become the latest pharma giants to strike price-reduction deals with the White House, agreeing to sell their weight loss drugs at cut-rate prices to patients in the U.S ...

The TL1a inhibitor duvakitug was effective at 14 weeks in patients who had previous exposure to conventional and advanced ...

Despite quarterly revenue totals that were nearly cut in half compared to the same period last year, Moderna still expects to ...